Bruker (BRKR) Operating Expenses (2010 - 2026)

Bruker has reported Operating Expenses for 17 years, with the latest figure at $369.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 2.84% year-over-year to $369.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 3.54% YoY), and the FY2025 full-year result was $1.5 billion, up 8.1% from the prior year.
• Operating Expenses for Q1 2026 stood at $369.6 million, down from $372.9 million in the prior quarter.
• The five-year high for Operating Expenses was $431.2 million in Q3 2025, with the low at $204.0 million in Q3 2022.
• Historically, Operating Expenses has averaged $307.3 million across 5 years, with a median of $326.8 million in 2023.
• Annual changes were most pronounced in 2023 — Operating Expenses soared 39.12% — and 2025, when it decreased 11.47%.
• Bruker's Operating Expenses stood at $234.9 million in 2022, then jumped by 39.12% to $326.8 million in 2023, then advanced by 28.89% to $421.2 million in 2024, then retreated by 11.47% to $372.9 million in 2025, then decreased by 0.88% to $369.6 million in 2026.
• The last three Operating Expenses figures came in at $369.6 million (Q1 2026), $372.9 million (Q4 2025), and $431.2 million (Q3 2025), per Business Quant data.